099430 — BioPlus Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for BioPlus Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,847	15,994	41,028	78,951	65,002
Net Total Accounts Receivable
Net Total Receivables	4,115	4,719	8,360	18,133	23,240
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10,902	25,738	54,416	106,059	97,336
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,964	7,408	22,013	27,873	56,478
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20,997	37,935	88,462	146,518	172,807
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,105	9,333	7,499	9,477	10,964
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,151	9,415	9,762	33,253	44,990
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	17,846	28,520	78,699	113,265	127,817
Total Liabilities & Shareholders' Equity	20,997	37,935	88,462	146,518	172,807
Total Common Shares Outstanding